Axelyf Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.63M
- Investors
-
4
Axelyf General Information
Description
Operator of a drug development company intended for metabolic diseases. The company utilizes a proprietary lipid nanoparticle delivery platform and an AI model for lipid design to advance drug candidates, including in vivo CAR-T programs for solid tumors and treatments for autoimmune hepatitis, enabling healthcare providers to address complex diseases where conventional medical approaches have been insufficient
Contact Information
Website
www.axelyf.comCorporate Office
- 33 Glenland Road
- Unit 2
- Chestnut Hill, MA 02467
- United States
Corporate Office
- 33 Glenland Road
- Unit 2
- Chestnut Hill, MA 02467
- United States
Axelyf Timeline
Axelyf Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 13-Oct-2026 | $2.63M | Completed | Pre-Clinical Trials | ||
| 2. Seed Round | 29-Aug-2025 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 02-Nov-2022 | $1.2M | $1.2M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Axelyf Signals
Axelyf Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 76Bio | VC-Backed Company | Minority | ||
| Omega ehf | Venture Capital | Minority | ||
| Silfurberg (Reykjavík) | Venture Capital | Minority | ||
| Brunnur Ventures | Venture Capital | Minority |
Axelyf Investments (1)
Axelyf’s most recent deal was a Corporate Asset Purchase with 76Bio (A Portfolio of Integrated Lipid Library Assets). The deal was made on 01-Aug-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 76Bio (A Portfolio of Integrated Lipid Library Assets) | 01-Aug-2024 | Corporate Asset Purchase | Buildings and Property |
Axelyf FAQs
-
When was Axelyf founded?
Axelyf was founded in 2022.
-
Where is Axelyf headquartered?
Axelyf is headquartered in Chestnut Hill, MA.
-
What is the size of Axelyf?
Axelyf has 10 total employees.
-
What industry is Axelyf in?
Axelyf’s primary industry is Drug Discovery.
-
Is Axelyf a private or public company?
Axelyf is a Private company.
-
What is Axelyf’s current revenue?
The current revenue for Axelyf is .
-
How much funding has Axelyf raised over time?
Axelyf has raised $7.13M.
-
Who are Axelyf’s investors?
76Bio, Omega ehf, Silfurberg (Reykjavík), and Brunnur Ventures have invested in Axelyf.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process